QuickView for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=38C26B15A34919197C7BA18757707959 (gene)

1. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
2. Irreversible Antagonists for the Adenosine A2B Receptor.
3. A patent review of adenosine A2B receptor antagonists (2016-present).
4. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Can…

There were no clinical trials for ADORA2B;jsessionid=01DC8EB23C428BB3B92744CA02AC630F;jsessionid=38C26B15A34919197C7BA18757707959